323 related articles for article (PubMed ID: 29688269)
21. Adiponectin and its receptors in the ovary: further evidence for a link between obesity and hyperandrogenism in polycystic ovary syndrome.
Comim FV; Hardy K; Franks S
PLoS One; 2013; 8(11):e80416. PubMed ID: 24260388
[TBL] [Abstract][Full Text] [Related]
22. Regulation of androgen receptor signaling by ubiquitination during folliculogenesis and its possible dysregulation in polycystic ovarian syndrome.
Lim JJ; Lima PDA; Salehi R; Lee DR; Tsang BK
Sci Rep; 2017 Aug; 7(1):10272. PubMed ID: 28860512
[TBL] [Abstract][Full Text] [Related]
23. Omentin and chemerin and their association with obesity in women with polycystic ovary syndrome.
Guzel EC; Celik C; Abali R; Kucukyalcin V; Celik E; Guzel M; Yilmaz M
Gynecol Endocrinol; 2014 Jun; 30(6):419-22. PubMed ID: 24524360
[TBL] [Abstract][Full Text] [Related]
24. Elevated serum chemerin in Chinese women with hyperandrogenic PCOS.
Wang L; Zhong Y; Ding Y; Shi X; Huang J; Zhu F
Gynecol Endocrinol; 2014 Oct; 30(10):746-50. PubMed ID: 24927079
[TBL] [Abstract][Full Text] [Related]
25. Insulin-like factor 3: a new circulating hormone related to luteinizing hormone-dependent ovarian hyperandrogenism in the polycystic ovary syndrome.
Gambineri A; Patton L; De Iasio R; Palladoro F; Pagotto U; Pasquali R
J Clin Endocrinol Metab; 2007 Jun; 92(6):2066-73. PubMed ID: 17356050
[TBL] [Abstract][Full Text] [Related]
26. The effect of ellagic acid on sex hormones and miRNA-21 expression in rats with polycystic ovary syndrome.
Khoshvaghti A; Rahbari R
Naunyn Schmiedebergs Arch Pharmacol; 2024 Jun; 397(6):4263-4273. PubMed ID: 38078918
[TBL] [Abstract][Full Text] [Related]
27. The effect of androgens on ovarian follicle maturation: Dihydrotestosterone suppress FSH-stimulated granulosa cell proliferation by upregulating PPARγ-dependent PTEN expression.
Chen MJ; Chou CH; Chen SU; Yang WS; Yang YS; Ho HN
Sci Rep; 2015 Dec; 5():18319. PubMed ID: 26674985
[TBL] [Abstract][Full Text] [Related]
28. Angiopoietins/TIE2 system and VEGF are involved in ovarian function in a DHEA rat model of polycystic ovary syndrome.
Abramovich D; Irusta G; Bas D; Cataldi NI; Parborell F; Tesone M
Endocrinology; 2012 Jul; 153(7):3446-56. PubMed ID: 22577112
[TBL] [Abstract][Full Text] [Related]
29. [Anti-Mullerian hormone- its role in the pathogenesis of the polycystic ovary syndrome].
Parahuleva N; Pehlivanov B; Dimitrakova E; Malinova M; Mladenova M
Akush Ginekol (Sofiia); 2012; 51(6):22-6. PubMed ID: 23390860
[TBL] [Abstract][Full Text] [Related]
30. Apoptosis and expression of protein TRAIL in granulosa cells of rats with polycystic ovarian syndrome.
Zhang J; Zhu G; Wang X; Xu B; Hu L
J Huazhong Univ Sci Technolog Med Sci; 2007 Jun; 27(3):311-4. PubMed ID: 17641850
[TBL] [Abstract][Full Text] [Related]
31. Immunohistochemical study of steroidogenesis and cell proliferation in polycystic ovarian syndrome.
Takayama K; Fukaya T; Sasano H; Funayama Y; Suzuki T; Takaya R; Wada Y; Yajima A
Hum Reprod; 1996 Jul; 11(7):1387-92. PubMed ID: 8671472
[TBL] [Abstract][Full Text] [Related]
32. Ovarian steroidal response to gonadotropins and beta-adrenergic stimulation is enhanced in polycystic ovary syndrome: role of sympathetic innervation.
Barria A; Leyton V; Ojeda SR; Lara HE
Endocrinology; 1993 Dec; 133(6):2696-703. PubMed ID: 8243293
[TBL] [Abstract][Full Text] [Related]
33. The role of macrophages in polycystic ovarian syndrome and its typical pathological features: A narrative review.
Feng Y; Tang Z; Zhang W
Biomed Pharmacother; 2023 Nov; 167():115470. PubMed ID: 37716116
[TBL] [Abstract][Full Text] [Related]
34. Angiotensin II type 2 receptor stimulation improves fatty acid ovarian uptake and hyperandrogenemia in an obese rat model of polycystic ovary syndrome.
Leblanc S; Battista MC; Noll C; Hallberg A; Gallo-Payet N; Carpentier AC; Vine DF; Baillargeon JP
Endocrinology; 2014 Sep; 155(9):3684-93. PubMed ID: 24971613
[TBL] [Abstract][Full Text] [Related]
35. Serum granulosa cell-derived TNF-α promotes inflammation and apoptosis of renal tubular cells and PCOS-related kidney injury through NF-κB signaling.
Ye HY; Song YL; Ye WT; Xiong CX; Li JM; Miao JH; Shen WW; Li XL; Zhou LL
Acta Pharmacol Sin; 2023 Dec; 44(12):2432-2444. PubMed ID: 37507430
[TBL] [Abstract][Full Text] [Related]
36. Higher levels of circulating chemerin in both lean and obese patients with polycystic ovary syndrome.
Ademoglu E; Berberoglu Z; Carlioglu A; Dellal F; Gorar S; Alphan Z; Uysal S; Karakurt F
Minerva Ginecol; 2014 Dec; 66(6):535-42. PubMed ID: 25373013
[TBL] [Abstract][Full Text] [Related]
37. SARS-CoV-2 Viral Entry Proteins in Hyperandrogenemic Female Mice: Implications for Women with PCOS and COVID-19.
Huffman AM; Rezq S; Basnet J; Yanes Cardozo LL; Romero DG
Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33922918
[TBL] [Abstract][Full Text] [Related]
38. Haplosufficient genomic androgen receptor signaling is adequate to protect female mice from induction of polycystic ovary syndrome features by prenatal hyperandrogenization.
Caldwell AS; Eid S; Kay CR; Jimenez M; McMahon AC; Desai R; Allan CM; Smith JT; Handelsman DJ; Walters KA
Endocrinology; 2015 Apr; 156(4):1441-52. PubMed ID: 25643156
[TBL] [Abstract][Full Text] [Related]
39. Uncoupling protein 2 expression affects androgen synthesis in polycystic ovary syndrome.
Liu Y; Jiang H; Xing FQ; Huang WJ; Mao LH; He LY
Endocrine; 2013 Jun; 43(3):714-23. PubMed ID: 23008094
[TBL] [Abstract][Full Text] [Related]
40. Polycystic ovaries are common in women with hyperandrogenic chronic anovulation but do not predict metabolic or reproductive phenotype.
Legro RS; Chiu P; Kunselman AR; Bentley CM; Dodson WC; Dunaif A
J Clin Endocrinol Metab; 2005 May; 90(5):2571-9. PubMed ID: 15713728
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
